Home / Chemicals & Advanced Materials

Global Ioversol Market Study 2016-2026, by Segment (Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240), … …), by Market (X-ray, CT Scan, … …), by Company (Liebel-Flarsheim Company LLC, Guerbet, …

SKU ID :99ST-14073099 | Published Date: 16-Oct-2019 | No. of pages: 56
Summary

The global Ioversol market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):


Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Demand Coverage (Market Size & Forecast, Consumer Distribution):
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others

Company Coverage (Sales data, Main Products & Services etc.):


Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company

Major Region

Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
  • PRICE
  • $1800
    $3600
    Buy Now

Our Clients